Skip to main content

Main menu

  • Home
  • Content
    • Current
      • JNMT Supplement
    • Ahead of print
    • Past Issues
    • Continuing Education
    • JNMT Podcast
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
    • Institutional and Non-member
  • Authors
    • Submit to JNMT
    • Information for Authors
    • Assignment of Copyright
    • AQARA Requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNMT
    • JNM
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine Technology
  • SNMMI
    • JNMT
    • JNM
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine Technology

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • Continuing Education
    • JNMT Podcast
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
    • Institutional and Non-member
  • Authors
    • Submit to JNMT
    • Information for Authors
    • Assignment of Copyright
    • AQARA Requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Watch or Listen to JNMT Podcast
  • Visit SNMMI on Facebook
  • Join SNMMI on LinkedIn
  • Follow SNMMI on Twitter
  • Subscribe to JNMT RSS feeds
Research ArticleImaging

Biodistribution and Dosimetry of Indigenously Produced 131I-Rituximab in B-Cell Lymphoma: Pilot Study Estimating Patient-Specific Dose Comparing 2 Different Dosimetric Methods

Aadil Adnan, Kamal Deep, Mythilli Kameswaran, Dilip Nikam, Chandrakala Shanmukaih, Ashutosh Dash, Sharmila Banerjee and Sandip Basu
Journal of Nuclear Medicine Technology December 2019, 47 (4) 292-299; DOI: https://doi.org/10.2967/jnmt.118.216754
Aadil Adnan
1Radiation Medicine Centre, Bhabha Atomic Research Centre, Tata Memorial Centre Annexe, Mumbai, India
2Homi Bhabha National Institute, Mumbai, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kamal Deep
2Homi Bhabha National Institute, Mumbai, India
3Radiation Safety Systems Division, Cama and Albless Hospital, Mumbai, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mythilli Kameswaran
2Homi Bhabha National Institute, Mumbai, India
4Radiopharmaceutical Division, Cama and Albless Hospital, Mumbai, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dilip Nikam
5Department of Radiotherapy and Oncology, Cama and Albless Hospital, Mumbai, India; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chandrakala Shanmukaih
6Department of Hematology, King Edward Memorial Hospital, Mumbai, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ashutosh Dash
2Homi Bhabha National Institute, Mumbai, India
4Radiopharmaceutical Division, Cama and Albless Hospital, Mumbai, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sharmila Banerjee
1Radiation Medicine Centre, Bhabha Atomic Research Centre, Tata Memorial Centre Annexe, Mumbai, India
2Homi Bhabha National Institute, Mumbai, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sandip Basu
1Radiation Medicine Centre, Bhabha Atomic Research Centre, Tata Memorial Centre Annexe, Mumbai, India
2Homi Bhabha National Institute, Mumbai, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 47 no. 4 292-299
DOI 
https://doi.org/10.2967/jnmt.118.216754
PubMed 
30413603

Published By 
Society of Nuclear Medicine
Print ISSN 
0091-4916
Online ISSN 
1535-5675
History 
  • Received for publication June 28, 2018
  • Accepted for publication October 2, 2018
  • Published online December 4, 2019.

Article Versions

  • previous version (November 9, 2018 - 09:05).
  • You are viewing the most recent version of this article.
Copyright & Usage 
© 2019 by the Society of Nuclear Medicine and Molecular Imaging.

Author Information

  1. Aadil Adnan1,2,
  2. Kamal Deep2,3,
  3. Mythilli Kameswaran2,4,
  4. Dilip Nikam5,
  5. Chandrakala Shanmukaih6,
  6. Ashutosh Dash2,4,
  7. Sharmila Banerjee1,2 and
  8. Sandip Basu1,2
  1. 1Radiation Medicine Centre, Bhabha Atomic Research Centre, Tata Memorial Centre Annexe, Mumbai, India
  2. 2Homi Bhabha National Institute, Mumbai, India
  3. 3Radiation Safety Systems Division, Cama and Albless Hospital, Mumbai, India
  4. 4Radiopharmaceutical Division, Cama and Albless Hospital, Mumbai, India
  5. 5Department of Radiotherapy and Oncology, Cama and Albless Hospital, Mumbai, India; and
  6. 6Department of Hematology, King Edward Memorial Hospital, Mumbai, India
  1. For correspondence or reprints contact: Sandip Basu, Radiation Medicine Centre, Bhabha Atomic Research Centre, Tata Memorial Hospital Annexe, Jerbai Wadia Rd., Parel, Mumbai, Maharashtra, India, 400 012. E-mail: drsanb{at}yahoo.com
View Full Text

Statistics from Altmetric.com

Cited By...

  • 1 Citations
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • Internal dosimetry and biodistribution of indigenously prepared 177Lu-DOTA-rituximab in lymphoma and other hematological malignancies treated with rituximab
    Yeshwanth Edamadaka, Rahul V. Parghane, Sudeep Sahu, Sangita Lad, Kamaldeep, Gaurav Wanage, Chandrakala Shanmukhaiah, Vrinda Kulkarni, Sandip Basu
    Nuclear Medicine Communications 2024 45 10

Article usage

Article usage: November 2018 to April 2025

AbstractFullPdf
Nov 20189809
Dec 20189402
Jan 20199403
Feb 20197604
Mar 20197301
Apr 20196200
May 20193900
Jun 20194400
Jul 20194500
Aug 20194000
Sep 20193600
Oct 20194501
Nov 201951010
Dec 201919126
Jan 2020164414
Feb 202019807
Mar 202012638
Apr 20207823
May 20206628
Jun 20205903
Jul 20203302
Aug 20203304
Sep 20203504
Oct 20205002
Nov 20204715
Dec 20201657
Jan 202118810
Feb 2021171919
Mar 2021132412
Apr 202114813
May 202117139
Jun 202114137
Jul 202182320
Aug 20218157
Sep 2021231716
Oct 202191624
Nov 2021251922
Dec 202116158
Jan 20227208
Feb 202210910
Mar 202252337
Apr 202261812
May 2022111913
Jun 202241217
Jul 20227123
Aug 20222810
Sep 2022101115
Oct 2022897
Nov 202210910
Dec 202271112
Jan 2023444
Feb 20231085
Mar 2023599
Apr 202371910
May 202316189
Jun 202321012
Jul 20236129
Aug 202351415
Sep 20236144
Oct 2023131814
Nov 202391911
Dec 202343514
Jan 20243484
Feb 202450218
Mar 202411179
Apr 2024102211
May 2024133717
Jun 2024193321
Jul 2024123613
Aug 202494621
Sep 2024263330
Oct 2024122421
Nov 2024192612
Dec 202472717
Jan 20254149
Feb 202574417
Mar 202595424
Apr 2025122029
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine Technology: 47 (4)
Journal of Nuclear Medicine Technology
Vol. 47, Issue 4
December 1, 2019
  • Table of Contents
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine Technology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Biodistribution and Dosimetry of Indigenously Produced 131I-Rituximab in B-Cell Lymphoma: Pilot Study Estimating Patient-Specific Dose Comparing 2 Different Dosimetric Methods
(Your Name) has sent you a message from Journal of Nuclear Medicine Technology
(Your Name) thought you would like to see the Journal of Nuclear Medicine Technology web site.
Citation Tools
Biodistribution and Dosimetry of Indigenously Produced 131I-Rituximab in B-Cell Lymphoma: Pilot Study Estimating Patient-Specific Dose Comparing 2 Different Dosimetric Methods
Aadil Adnan, Kamal Deep, Mythilli Kameswaran, Dilip Nikam, Chandrakala Shanmukaih, Ashutosh Dash, Sharmila Banerjee, Sandip Basu
Journal of Nuclear Medicine Technology Dec 2019, 47 (4) 292-299; DOI: 10.2967/jnmt.118.216754

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Biodistribution and Dosimetry of Indigenously Produced 131I-Rituximab in B-Cell Lymphoma: Pilot Study Estimating Patient-Specific Dose Comparing 2 Different Dosimetric Methods
Aadil Adnan, Kamal Deep, Mythilli Kameswaran, Dilip Nikam, Chandrakala Shanmukaih, Ashutosh Dash, Sharmila Banerjee, Sandip Basu
Journal of Nuclear Medicine Technology Dec 2019, 47 (4) 292-299; DOI: 10.2967/jnmt.118.216754
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • DISCLOSURE
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Early 10-Minute Postinjection [18F]F-FAPI-42 uEXPLORER Total-Body PET/CT Scanning Protocol for Staging Lung Cancer Using HYPER Iterative Reconstruction
  • Single- Versus Dual-Time-Point Imaging for Transthyretin Cardiac Amyloid Using 99mTc-Pyrophosphate
  • Monte Carlo Simulation of Characteristics of Discovery NM/CT 670 Pro SPECT System for Routinely Used Diagnostic and Therapeutic Radionuclides
Show more Imaging

Similar Articles

Keywords

  • 131I-Rituximab
  • B-Cell Lymphoma
  • Radioimmunotherapy
  • dosimetry
SNMMI

© 2025 SNMMI

Powered by HighWire